| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/JAC/DKG256 |
| P8608 | Fatcat ID | release_l4edeco3hnbldkdih5ehvfrjty |
| P698 | PubMed publication ID | 12775683 |
| P2093 | author name string | Bonnet R | |
| De Champs C | |||
| Sirot J | |||
| Chanal C | |||
| Sirot D | |||
| Recule C | |||
| Baraduc R | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 29-35 | |
| P577 | publication date | 2003-05-29 | |
| P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
| P1476 | title | Effect of D240G substitution in a novel ESBL CTX-M-27. | |
| P478 | volume | 52 |
| Q91405164 | An Escherichia coli ST131 pangenome atlas reveals population structure and evolution across 4,071 isolates |
| Q57174339 | Antibacterial Spectrum of a Tetrazole-Based Reversible Inhibitor of Serine β-Lactamases |
| Q28486539 | Biochemical characterization of CTX-M-15 from Enterobacter cloacae and designing a novel non-β-lactam-β-lactamase inhibitor |
| Q37203750 | CTX-M beta-lactamases in Escherichia coli from community-acquired urinary tract infections, Cambodia. |
| Q41036064 | CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea |
| Q36748380 | CTX-M-27 Producing Salmonella enterica Serotypes Typhimurium and Indiana Are Prevalent among Food-Producing Animals in China |
| Q41480033 | CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic |
| Q34932847 | CTX-M-93, a CTX-M variant lacking penicillin hydrolytic activity |
| Q35482523 | CTX-M-producing non-Typhi Salmonella spp. isolated from humans, United States |
| Q35754705 | Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases |
| Q54240932 | Characterization of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae from Riyadh, Saudi Arabia. |
| Q35940783 | Characterization of extended-spectrum β-lactamase genes found among Escherichia coli isolates from duck and environmental samples obtained on a duck farm |
| Q36158271 | Characterization of the global stabilizing substitution A77V and its role in the evolution of CTX-M β-lactamases |
| Q37598697 | Community-onset disease caused by Citrobacter freundii producing a novel CTX-M beta-lactamase, CTX-M-30, in Canada |
| Q37287712 | Comparative Characterization of CTX-M-64 and CTX-M-14 Provides Insights into the Structure and Catalytic Activity of the CTX-M Class of Enzymes. |
| Q37568365 | Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada |
| Q43111722 | Convergent in vivo and in vitro selection of ceftazidime resistance mutations at position 167 of CTX-M-3 beta-lactamase in hypermutable Escherichia coli strains. |
| Q53697061 | Defining substrate specificity in the CTX-M family: the role of Asp240 in ceftazidime hydrolysis. |
| Q40157848 | Detection of emerging antibiotic resistance in bacteria isolated from subclinical mastitis in cattle in West Bengal |
| Q42799124 | Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures |
| Q35041607 | Direct RNA-based detection and differentiation of CTX-M-type extended-spectrum β-lactamases (ESBL). |
| Q38282801 | Distant and new mutations in CTX-M-1 beta-lactamase affect cefotaxime hydrolysis |
| Q38018625 | Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria |
| Q30276256 | Excess positional mutual information predicts both local and allosteric mutations affecting beta lactamase drug resistance |
| Q28354075 | First Report of Group CTX-M-9 Extended Spectrum Beta-Lactamases in Escherichia coli Isolates from Pediatric Patients in Mexico |
| Q27651194 | Genetic and Structural Insights into the Dissemination Potential of the Extremely Broad-Spectrum Class A -Lactamase KPC-2 Identified in an Escherichia coli Strain and an Enterobacter cloacae Strain Isolated from the Same Patient in France |
| Q35006613 | Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes |
| Q34139107 | High-level resistance to ceftazidime conferred by a novel enzyme, CTX-M-32, derived from CTX-M-1 through a single Asp240-Gly substitution |
| Q42910056 | Human Salmonella infection yielding CTX-M beta-lactamase, United States |
| Q43126004 | In vitro activity of ceftolozane-tazobactam as determined by broth dilution and agar diffusion assays against recent U.S. Escherichia coli isolates from 2010 to 2011 carrying CTX-M-type extended-spectrum β-lactamases |
| Q91995139 | Independent Host Factors and Bacterial Genetic Determinants of the Emergence and Dominance of Escherichia coli Sequence Type 131 CTX-M-27 in a Community Pediatric Cohort Study |
| Q42412646 | Interaction of CTX-M-15 enzyme with cefotaxime: a molecular modelling and docking study |
| Q37624427 | Molecular and kinetic comparison of the novel extended-spectrum beta-lactamases CTX-M-25 and CTX-M-26. |
| Q37504205 | Molecular characteristics of extended-spectrum β-lactamase-producing Escherichia coli in Riyadh: emergence of CTX-M-15-producing E. coli ST131. |
| Q30430793 | Molecular characteristics of extended-spectrum β-lactamases in clinical isolates from Escherichia coli at a Japanese tertiary hospital |
| Q35758933 | Molecular epidemiology of CTX-M-producing Escherichia coli in the Calgary Health Region: emergence of CTX-M-15-producing isolates |
| Q37196263 | Multidrug-Resistant Shigella Infections in Patients with Diarrhea, Cambodia, 2014-2015. |
| Q40631519 | Multilocus sequence typing and CTX-M characterization of ESBL-producing E. coli: a prospective single-centre study in Lower Saxony, Germany |
| Q39991540 | Nationwide survey of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in the French community setting |
| Q28547682 | Natural Variants of the KPC-2 Carbapenemase have Evolved Increased Catalytic Efficiency for Ceftazidime Hydrolysis at the Cost of Enzyme Stability |
| Q33752900 | Nosocomial outbreak caused by Salmonella enterica serotype Livingstone producing CTX-M-27 extended-spectrum beta-lactamase in a neonatal unit in Sousse, Tunisia. |
| Q37032894 | Novel chimeric beta-lactamase CTX-M-64, a hybrid of CTX-M-15-like and CTX-M-14 beta-lactamases, found in a Shigella sonnei strain resistant to various oxyimino-cephalosporins, including ceftazidime |
| Q37190813 | Novel plasmid-encoded ceftazidime-hydrolyzing CTX-M-53 extended-spectrum beta-lactamase from Salmonella enterica serotypes Westhampton and Senftenberg. |
| Q45840163 | Phenotypic and molecular characterization of two novel CTX-M enzymes carried by Klebsiella pneumoniae |
| Q40616155 | Predictability of Phenotype in Relation to Common β-Lactam Resistance Mechanisms in Escherichia coli and Klebsiella pneumoniae. |
| Q34352214 | Prediction of the evolution of ceftazidime resistance in extended-spectrum beta-lactamase CTX-M-9. |
| Q42688454 | Prolonged febrile illness due to CTX-M-15 extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection in Nigeria |
| Q35758887 | Rapid genotyping of CTX-M extended-spectrum beta-lactamases by denaturing high-performance liquid chromatography |
| Q36075902 | Residues Distal to the Active Site Contribute to Enhanced Catalytic Activity of Variant and Hybrid β-Lactamases Derived from CTX-M-14 and CTX-M-15 |
| Q39916554 | Resistance patterns, ESBL genes, and genetic relatedness of Escherichia coli from dogs and owners. |
| Q52661545 | Structural and Mechanistic Basis for Extended-Spectrum Drug-Resistance Mutations in Altering the Specificity of TEM, CTX-M, and KPC β-lactamases. |
| Q42379531 | The Drug-Resistant Variant P167S Expands the Substrate Profile of CTX-M β-Lactamases for Oxyimino-Cephalosporin Antibiotics by Enlarging the Active Site upon Acylation |
| Q22065663 | The emergence of antibiotic resistance by mutation |
| Q37428648 | Whole-Genome Sequencing Identifies In Vivo Acquisition of a blaCTX-M-27-Carrying IncFII Transmissible Plasmid as the Cause of Ceftriaxone Treatment Failure for an Invasive Salmonella enterica Serovar Typhimurium Infection |
Search more.